SEC 13F Intelligence

Elk Creek Partners, LLC / AM6

Elk Creek Partners, LLC’s Amicus Therapeutic Position

Does Elk Creek Partners, LLC own Amicus Therapeutic (AM6)? Yes — 935.0K shares worth $9M (+1.48% of its 13F portfolio) as of Q1 2020, up from 859.3K shares the prior filed quarter.

Position Value
$9M
Q1 2020
Shares
935.0K
% of Portfolio
+1.48%
Quarters Held
5
currently held

Position History AM6

Reported value by quarter
Q1 ’19: $7MQ1 ’19Q2 ’19: $10MQ2 ’19Q3 ’19: $8MQ3 ’19Q4 ’19: $8MQ4 ’19Q1 ’20: $9MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020935.0K$9M+1.48%
Q4 2019859.3K$8M+0.96%
Q3 2019990.8K$8M+0.68%
Q2 2019818.2K$10M+0.76%
Q1 2019536.2K$7M+0.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Elk Creek Partners, LLC’s full portfolio or all institutional holders of AM6.